189 related articles for article (PubMed ID: 20576846)
1. Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome.
Huijing PA; Voermans NC; Baan GC; Busé TE; van Engelen BG; de Haan A
J Appl Physiol (1985); 2010 Oct; 109(4):986-95. PubMed ID: 20576846
[TBL] [Abstract][Full Text] [Related]
2. Mild muscular features in tenascin-X knockout mice, a model of Ehlers-danlos syndrome.
Voermans NC; Verrijp K; Eshuis L; Balemans MC; Egging D; Sterrenburg E; van Rooij IA; van der Laak JA; Schalkwijk J; van der Maarel SM; Lammens M; van Engelen BG
Connect Tissue Res; 2011 Oct; 52(5):422-32. PubMed ID: 21405982
[TBL] [Abstract][Full Text] [Related]
3. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome.
Burch GH; Gong Y; Liu W; Dettman RW; Curry CJ; Smith L; Miller WL; Bristow J
Nat Genet; 1997 Sep; 17(1):104-8. PubMed ID: 9288108
[TBL] [Abstract][Full Text] [Related]
4. Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition.
Egging D; van Vlijmen-Willems I; van Tongeren T; Schalkwijk J; Peeters A
Connect Tissue Res; 2007; 48(2):93-8. PubMed ID: 17453911
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition.
Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J
Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569
[TBL] [Abstract][Full Text] [Related]
6. Reduced quantitative muscle function in tenascin-X deficient Ehlers-Danlos patients.
Voermans NC; Altenburg TM; Hamel BC; de Haan A; van Engelen BG
Neuromuscul Disord; 2007 Aug; 17(8):597-602. PubMed ID: 17588758
[TBL] [Abstract][Full Text] [Related]
7. Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations.
Zweers MC; Dean WB; van Kuppevelt TH; Bristow J; Schalkwijk J
Clin Genet; 2005 Apr; 67(4):330-4. PubMed ID: 15733269
[TBL] [Abstract][Full Text] [Related]
8. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J
N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233
[TBL] [Abstract][Full Text] [Related]
9. Dermal connective tissue development in mice: an essential role for tenascin-X.
Egging DF; van Vlijmen I; Starcher B; Gijsen Y; Zweers MC; Blankevoort L; Bristow J; Schalkwijk J
Cell Tissue Res; 2006 Mar; 323(3):465-74. PubMed ID: 16331473
[TBL] [Abstract][Full Text] [Related]
10. Interactions of human tenascin-X domains with dermal extracellular matrix molecules.
Egging D; van den Berkmortel F; Taylor G; Bristow J; Schalkwijk J
Arch Dermatol Res; 2007 Jan; 298(8):389-96. PubMed ID: 17033827
[TBL] [Abstract][Full Text] [Related]
11. A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function.
Aktar R; Peiris M; Fikree A; Eaton S; Kritas S; Kentish SJ; Araujo EJA; Bacarin C; Page AJ; Voermans NC; Aziz Q; Blackshaw LA
J Physiol; 2019 Mar; 597(6):1503-1515. PubMed ID: 30605228
[TBL] [Abstract][Full Text] [Related]
12. Titin-based stiffening of muscle fibers in Ehlers-Danlos Syndrome.
Ottenheijm CA; Voermans NC; Hudson BD; Irving T; Stienen GJ; van Engelen BG; Granzier H
J Appl Physiol (1985); 2012 Apr; 112(7):1157-65. PubMed ID: 22223454
[TBL] [Abstract][Full Text] [Related]
13. Mechanical allodynia in mice with tenascin-X deficiency associated with Ehlers-Danlos syndrome.
Okuda-Ashitaka E; Kakuchi Y; Kakumoto H; Yamanishi S; Kamada H; Yoshidu T; Matsukawa S; Ogura N; Uto S; Minami T; Ito S; Matsumoto KI
Sci Rep; 2020 Apr; 10(1):6569. PubMed ID: 32300146
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular involvement in various types of Ehlers-Danlos syndrome.
Voermans NC; van Alfen N; Pillen S; Lammens M; Schalkwijk J; Zwarts MJ; van Rooij IA; Hamel BC; van Engelen BG
Ann Neurol; 2009 Jun; 65(6):687-97. PubMed ID: 19557868
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular properties of the thigh muscles in patients with Ehlers-Danlos syndrome.
Gerrits KH; Voermans NC; de Haan A; van Engelen BG
Muscle Nerve; 2013 Jan; 47(1):96-104. PubMed ID: 23169204
[TBL] [Abstract][Full Text] [Related]
16. Analysis of obstetric complications and uterine connective tissue in tenascin-X-deficient humans and mice.
Egging DF; van Vlijmen-Willems I; Choi J; Peeters AC; van Rens D; Veit G; Koch M; Davis EC; Schalkwijk J
Cell Tissue Res; 2008 Jun; 332(3):523-32. PubMed ID: 18335242
[TBL] [Abstract][Full Text] [Related]
17. Distribution of extracellular matrix tenascin-X in sciatic nerves.
Matsumoto K; Sawa H; Sato M; Orba Y; Nagashima K; Ariga H
Acta Neuropathol; 2002 Nov; 104(5):448-54. PubMed ID: 12410392
[TBL] [Abstract][Full Text] [Related]
18. Wound healing-related properties detected in an experimental model with a collagen gel contraction assay are affected in the absence of tenascin-X.
Hashimoto K; Kajitani N; Miyamoto Y; Matsumoto KI
Exp Cell Res; 2018 Feb; 363(1):102-113. PubMed ID: 29291401
[TBL] [Abstract][Full Text] [Related]
19. Finite element modeling of aponeurotomy: altered intramuscular myofascial force transmission yields complex sarcomere length distributions determining acute effects.
Yucesoy CA; Koopman BH; Grootenboer HJ; Huijing PA
Biomech Model Mechanobiol; 2007 Jul; 6(4):227-43. PubMed ID: 16897102
[TBL] [Abstract][Full Text] [Related]
20. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X.
Kolli V; Kim H; Rao H; Lao Q; Gaynor A; Milner JD; Merke DP
BMC Res Notes; 2019 Oct; 12(1):711. PubMed ID: 31666125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
